FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for[...]
Endo Provides Top-Line Results from Phase 2 Study of Collagenase[...]
05/24/2022 | Press release | Distributed by Public on 05/24/2022 15:30
Please select the service you want to use:
Smartlinks | Dillard's Inc. | News | Local News | Conglomerates and Diversified | Company News | Shareholders | Internal Dealings | Retail | Department Stores | Public Companies | Department Stores | New York Stock Exchange (NYSE) | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | BX Swiss | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact